Miraftab M, Qiao Q, Kennedy J F, Groocock M R, Anand S C
Bolton Institute, Faculty of Technology, Bolton, UK.
J Wound Care. 2002 Oct;11(9):353-6. doi: 10.12968/jowc.2002.11.9.26436.
This laboratory-based study set out to establish whether branan ferulate--a polysaccharide compound available in gels such as as Sterigel (SSL International, UK)--could be successfully added to the fibre of an alginate dressing to provide a superior wound-care dressing.
A wet extruder (Howden Engineering Services, UK) was used to produce the fibres. Researchers examined the effect of spinning-bath calcium chloride concentration (used as the coagulant in the fibre-spinning process) on the tensile and absorption properties of alginate fibres containing 25% w/w branan ferulate. Sodium alginate and branan ferulate were separately dissolved in de-ionised water and then stirred together to make up a 5% dope solution. The dope was then forced through a spinneret and into the calcium chloride bath, where fibres were precipitated and then carried over the first set of rollers. The fibres were washed in the next bath and drawn at different rates to enhance their tensile properties. At the 'winding-up' stage the filaments were either passed over a contact heater and into a furnace (dry pick-up) or transferred into acetone baths of increasing concentrations of 50, 80 and 100% aqueous acetate to remove the water (wet pick-up). The moisture content of standard alginate fibres and those with branan ferulate were measured and compared. Breaking load, tenacity and breaking extension, and the quantity of branan ferulate in the fibres were also measured. The process was repeated four times, using different strengths of calcium chloride. Using various draw ratios, the effects of liquid uptake were measured using water, saline and a solution called A (to mimic human blood and exudate-type fluids).
Out of the four calcium chloride concentrations used, 1% concentration appeared to give the highest and most conclusive results for fibre-breaking load, tenacity and breaking extension.
A 1% w/v concentration of calcium chloride provides the optimum conditions for achieving suitably strong fibres with adequate absorption capacity, while allowing the least branan ferulate loss during wash and post-production treatments. In a laboratory setting the product showed promise. Research is now needed in a clinical setting and for comparison with existing wound-care products.
这项基于实验室的研究旨在确定阿魏酸米糠聚糖(一种存在于如Sterigel(英国SSL国际公司)等凝胶中的多糖化合物)是否能够成功添加到藻酸盐敷料的纤维中,以提供一种更优质的伤口护理敷料。
使用一台湿式挤出机(英国豪顿工程服务公司)来生产纤维。研究人员考察了纺丝浴氯化钙浓度(在纤维纺丝过程中用作凝固剂)对含有25%(重量/重量)阿魏酸米糠聚糖的藻酸盐纤维的拉伸性能和吸收性能的影响。海藻酸钠和阿魏酸米糠聚糖分别溶解于去离子水中,然后搅拌在一起配制成5%的纺丝原液。然后将纺丝原液通过喷丝头压入氯化钙浴中,在那里纤维沉淀下来,接着输送到第一组滚筒上。纤维在下一个浴中进行清洗,并以不同的速率拉伸以增强其拉伸性能。在“卷绕”阶段,长丝要么通过接触式加热器进入加热炉(干法收集),要么转移到浓度逐渐增加的50%、80%和100%的醋酸水溶液丙酮浴中以去除水分(湿法收集)。对标准藻酸盐纤维和含有阿魏酸米糠聚糖的纤维的水分含量进行了测量和比较。还测量了断裂负荷、韧性和断裂伸长率以及纤维中阿魏酸米糠聚糖的含量。该过程使用不同强度的氯化钙重复进行了四次。使用各种拉伸比,用水、盐水和一种名为A的溶液(模拟人体血液和渗出液类型的液体)测量了液体吸收的效果。
在所使用的四种氯化钙浓度中,1%的浓度似乎在纤维断裂负荷、韧性和断裂伸长率方面给出了最高且最具决定性的结果。
1%(重量/体积)浓度的氯化钙为获得具有足够吸收能力且强度合适的纤维提供了最佳条件,同时在洗涤和生产后处理过程中使阿魏酸米糠聚糖的损失最小。在实验室环境中,该产品显示出了前景。现在需要在临床环境中进行研究,并与现有的伤口护理产品进行比较。